EW - Edwards Lifesciences Corp


85.22
-0.060   -0.070%

Share volume: 4,146,460
Last Updated: 03-04-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%

$85.28
-0.06
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
83%
Profitability 92%
Dept financing 43%
Liquidity 55%
Performance 92%
Company vs Stock growth
vs
Performance
5 Days
-2.25%
1 Month
9.12%
3 Months
-1.13%
6 Months
5.29%
1 Year
16.98%
2 Year
-1.02%
Key data
Stock price
$85.22
P/E Ratio 
46.08
DAY RANGE
$84.22 - $85.80
EPS 
$1.84
52 WEEK RANGE
$65.94 - $87.89
52 WEEK CHANGE
$18.69
MARKET CAP 
49.471 B
YIELD 
N/A
SHARES OUTSTANDING 
580.800 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-23-2025
BETA 
0.66
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,692,954
AVERAGE 30 VOLUME 
$5,386,831
Company detail
CEO: Michael A. Mussallem
Region: US
Website: edwards.com
Employees: 17,300
IPO year: 2000
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, critical care and surgical monitoring. It offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name. The company distributes its products through a direct sales force and independent distributors.

Recent news